Free Shipping on Orders over $200
Unlock 10% Off with Email Signup
Same-Day Shipping Before 3 PM EST
Dispatched Within 24 Hours
Referenced in Human Studies
Third-Party COA Verified
Sourced from Trusted Labs in EU
Scientific Advisory Oversight
Retatrutide enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.
Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.
Our local team are here to help
Have more questions about peptide research? You’re not alone. Explore our Frequently Asked Questions for quick answers—or head to the Knowledge Base to explore study areas, calculators, and protocol guides.
Retatrutide is a triple agonist (GLP-1, GIP, glucagon receptors) studied for its role in energy regulation, glucose balance, and weight signaling in biological models.
It’s typically studied in extended-duration metabolic protocols.
Refrigerate after mixing and keep in a stable, temperature-controlled setting.
